KHOS-NP Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | KHOS-NP is a cell line derived from the HOS cell line through transformation with the Kirsten murine sarcoma virus (Ki-MSV). The transformation process has resulted in a highly tumorigenic cell line that is characterized by several distinct properties, making it valuable for specific research applications. Notably, the KHOS-NP cells are particularly useful for producing MSV pseudotypes with various ecotropic and xenotropic murine leukemia viruses, which is of interest in studies focused on viral replication, oncogenesis, and related pathways. KHOS-NP cells exhibit adherent growth properties and are derived from the bone tissue of a white, female adult. The cells carry the Ki-MSV genome but do not produce infectious virus particles or viral antigens, making them safe for certain in vitro research settings where infectious viral production would be a concern. Despite this, the KHOS-NP cells maintain a high saturation density and have a high plating efficiency in soft agar, demonstrating robust proliferative and anchorage-independent growth characteristics, which are typical of transformed and tumorigenic cell lines. In vivo, KHOS-NP cells are highly tumorigenic, with a 100% frequency of tumor formation observed in nude mice within 21 days post-inoculation when injected subcutaneously with 107 cells. These properties make the KHOS-NP cell line a valuable model for studying sarcoma development, tumor biology, and the molecular mechanisms underlying oncogenesis. However, it is essential to note that KHOS-NP cells are not suitable for therapeutic or in vivo applications, and their use should be restricted to controlled experimental conditions in a research setting. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Osteosarcoma |
| Synonyms | KHOS/NP, KHOS NP, KHOSNP, R-970-5, KHOS |
Characteristics
| Age | 13 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | KHOS-NP (Cytion catalog number 300235) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2546 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice. |
|---|
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|